（文章来源：证券日报） 证券日报网讯 11月19日晚间，上海雅仕发布公告称，公司于2025年11月19日召开第四届董事会第十三 次会议，审议通过了《关于使用募集资金置换已支付发行费用的自筹资金的议案》，同意公司使用募集 资金置换已支付发行费用的自筹资金，置换金额为人民币752，830.19元（不含税），本次募集资金置 换时间距募集资金到账日未超过6个月。 ...

证券日报网讯 11月19日晚间，上海雅仕发布公告称，公司于2025年11月19日召开第四届董事会第十三 次会议，审议通过了《关于增加募投项目实施主体并使用部分募集资金向新增实施主体提供借款以实施 募投项目的议案》，同意公司新增全资子公司湖北雅仕实业控股有限公司（简称"湖北雅仕"）作为募投 项目实施主体并开立募集资金专项账户，与公司共同实施"补充流动资金或偿还银行贷款项目"，并使用 部分募集资金向新增实施主体提供借款以实施募投项目。 （文章来源：证券日报） ...

Core Viewpoint - The company Shanghai Yashi Investment Development Co., Ltd. has approved a plan to utilize idle raised funds for cash management, aiming to enhance the efficiency of fund usage while ensuring normal operations and compliance with regulations [1][2]. Group 1: Cash Management Plan - The company will use up to 200 million yuan of idle raised funds for cash management, with an investment period of twelve months from the board's approval date [1]. - Investment products will focus on high safety and liquidity, including but not limited to seven-day notice deposits and fixed-term deposits [1]. - The funds will come from idle raised funds from a specific stock issuance in 2024, ensuring that all deposits are kept in established special accounts for raised funds [1]. Group 2: Risk Control and Compliance - The company will adhere to prudent investment principles, selecting quality investment targets and monitoring product allocation and project progress [1]. - The plan has received a no-objection opinion from the sponsor institution, confirming that it complies with relevant regulations and does not harm shareholder interests [2]. - The board has authorized the chairman and designated individuals to make investment decisions within the approved limits without needing to submit the proposal to the shareholders' meeting [2].

Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

Group 1 - The core point of the article is that Shanghai Yashi (SH 603329) held its 13th meeting of the fourth board of directors on November 19, 2025, to discuss the proposal for changing registered capital and amending the company's articles of association [1] - For the first half of 2025, Shanghai Yashi's revenue composition was as follows: supply chain execution trade accounted for 73.44%, multimodal transport 18.1%, third-party logistics services 7.87%, and other businesses 0.59% [1] - As of the report date, Shanghai Yashi's market capitalization was 3 billion yuan [1]

向新增实施主体提供借款以实施募投项目的核查意见 国联民生证券承销保荐有限公司（以下简称"保荐机构"）作为上海雅仕投 资发展股份有限公司（以下简称"上海雅仕"或"公司"）2024 年度向特定对象 发行 A 股股票的保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司 募集资金监管规则》《上海证券交易所股票上市规则》《上海证券交易所上市公司 自律监管指引第 1 号——规范运作》等有关规定，对上海雅仕增加募投项目实施 主体并使用部分募集资金向新增实施主体提供借款以实施募投项目事项进行了 审慎核查。核查的情况及核查意见如下： 国联民生证券承销保荐有限公司 关于上海雅仕投资发展股份有限公司 增加募投项目实施主体并使用部分募集资金 一、募集资金基本情况 （一）募集资金情况 经中国证券监督管理委员会《关于同意上海雅仕投资发展股份有限公司向特 定对象发行股票注册的批复》（证监许可〔2025〕1825 号）同意，公司本次向特 定对象发行人民币普通股（A 股）43,668,122 股，发行价格 6.87 元/股，募集资金 总额为 299,999,998.14 元，扣除不含税发行费用人民币 2,775,158.61 元，募集资 ...

国联民生证券承销保荐有限公司 关于上海雅仕投资发展股份有限公司 使用部分闲置募集资金进行现金管理的核查意见 国联民生证券承销保荐有限公司（以下简称"保荐机构"）作为上海雅仕投 资发展股份有限公司（以下简称"上海雅仕"或"公司"）2024 年度向特定对象 发行 A 股股票的保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司 募集资金监管规则》《上海证券交易所股票上市规则》《上海证券交易所上市公司 自律监管指引第 1 号——规范运作》等有关法律法规的规定，对上海雅仕使用部 分闲置募集资金进行现金管理事项进行了审慎核查。核查的情况及核查意见如 下： 一、投资情况概述 （一）投资目的 为提高上海雅仕募集资金使用效率，在不影响募集资金使用和公司正常经营 的情况下，公司将合理利用暂时闲置募集资金进行现金管理，增加资金收益，为 公司及股东获取投资回报。本次现金管理不会影响公司主营业务的发展，本次资 金使用安排合理。 （二）投资金额及期限 公司及子公司拟使用不超过 20,000 万元（含本数）的闲置募集资金进行现 金管理，有效期为自公司董事会审议通过之日起十二个月内有效。在上述额度及 有效期内，资金可循环滚动使用，期限 ...

国联民生证券承销保荐有限公司 关于上海雅仕投资发展股份有限公司 使用募集资金置换已支付发行费用的自筹资金的核查意见 国联民生证券承销保荐有限公司（以下简称"保荐机构"）作为上海雅仕投 资发展股份有限公司（以下简称"上海雅仕"或"公司"）2024 年度向特定对象 发行 A 股股票的保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司 募集资金监管规则》《上海证券交易所股票上市规则》《上海证券交易所上市公司 自律监管指引第 1 号——规范运作》等有关法律法规的规定，对上海雅仕使用募 集资金置换已支付发行费用的自筹资金事项进行了审慎核查。核查的情况及核查 意见如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意上海雅仕投资发展股份有限公司向特 定对象发行股票注册的批复》（证监许可〔2025〕1825 号）同意，公司本次向特 定对象发行人民币普通股（A 股）43,668,122 股，发行价格 6.87 元/股，募集资 金总额为 299,999,998.14 元，扣除不含税发行费用人民币 2,775,158.61 元，募集 资金净额为人民币 297,224,839.53 元。立信会计师事务所（特殊普通合 ...

| 1 | K | | --- | --- | | | | | 第一章 | 总则 1 | | | --- | --- | --- | | 第二章 | 经营宗旨和范围 | 2 | | 第三章 | 股份 2 | | | 第一节 | 股份发行 | 2 | | 第二节 | 股份增减和回购 | 4 | | 第三节 | 股份转让 | 5 | | 第四章 | 股东和股东会 | 6 | | 第一节 | 股东的一般规定 | 6 | | 第二节 | 控股股东和实际控制人 | 9 | | 第三节 | 股东会的一般规定 | 10 | | 第四节 | 股东会的召集 | 12 | | 第五节 | 股东会的提案与通知 | 14 | | 第六节 | 股东会的召开 | 15 | | 第七节 | 股东会的表决和决议 | 18 | | 第五章 | 董事会 | 22 | | 第一节 | 董事 | 22 | | 第二节 | 独立董事 | 25 | | 第三节 | 董事会 | 31 | | 第四节 | 董事会专门委员会 | 36 | | 第六章 | 高级管理人员 | 38 | | 第七章 | 党组织 | 40 | | 第一节 | 党组织及其产生和组织 ...

格隆汇11月19日丨上海雅仕(603329.SH)公布，公司及子公司拟使用不超过20,000万元（含本数）的闲置 募集资金进行现金管理，有效期为自公司董事会审议通过之日起十二个月内有效。在上述额度及有效期 内，资金可循环滚动使用，期限内任一时点的交易金额（含前述投资的收益进行再投资的相关金额）不 应超过投资额度。 ...